Related Experiment Video
Updated: May 9, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Over-the-counter contraceptive pill availability in New York State
Carolyn Joyce1, Komal Keerthy1, Sedna Gandhi2
1New York Medical College, Valhalla, NY, United States.
Objective:
To map access to norgestrel 0.075 mg (Opill) in New York state one year after approval for over-the-counter (OTC) sale.
Study Design:
We called a random sample of New York pharmacies posing as minors enquiring about Opill. We collected information about pharmacy type and location. We used the Chi Squared test to compare proportions.
Results:
Of the 379/7143 (3.5%) registered pharmacies reached, 214 (56.46%) stocked norgestrel and 76/165 (46.06%) could order it. The average monthly cost was $25.29. Chain pharmacies were more likely to stock than others (p < 0.001). There was no difference by location.
Conclusions:
The OTC contraceptive pill is not universally available in New York.
Implications:
Inconsistent pharmacy availability of the OTC contraceptive pill is liimiting its potential public health impact.
Related Concept Videos
Birth Control Methods
Intrauterine Drug Delivery Systems
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Oral Drug Delivery Systems: Continuous-Release Systems
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
